Literature DB >> 21033024

Use of ICF in assessing the effects of Meniere's disorder on life.

Hilla Levo1, Dafydd Stephens, Dennis Poe, Erna Kentala, Ilmari Pyykkö.   

Abstract

OBJECTIVES: We sought to determine the value of the World Health Organization's International Classification of Functioning, Disability and Health (ICF) in subjects with Meniere's disorder in relation to their quality of life.
METHODS: We asked 228 members of the Finnish Meniere Federation to report the effects that Meniere's disorder had on their lives. The replies were classified on the basis of the ICF classification and related to the EuroQol 5D score and disease-specific impact. Logistic regression and decision tree analyses were used to determine the relationships.
RESULTS: Seventy percent of the patients listed impairments, 39% activity limitations, 47% participation restrictions, 16% effects on environmental contextual factors, and 28% effects on personal contextual factors. The EuroQol 5D score was explained by reported vertigo, anxiety, fatigue, restriction of life, and communication problems. The disease-specific impact was explained by episodes of vertigo, fatigue, communication problems, inability to work, restriction of life, and uncertainty of life. Both analysis models provided the same outcome variables, although the decision tree separated the results better (80%) into correct classes than did logistic regression analysis (60%).
CONCLUSIONS: Self-reported participation restriction, activity limitation, and personal contextual factors describe the limitations of general life in subjects with Meniere's disorder. The use of the ICF classification provides an instrument that can be used in enablement of subjects with Meniere's disorder.

Entities:  

Mesh:

Year:  2010        PMID: 21033024     DOI: 10.1177/000348941011900903

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  7 in total

1.  Meniere's disease: a reappraisal supported by a variable latency of symptoms and the MRI visualisation of endolymphatic hydrops.

Authors:  Ilmari Pyykkö; Tsutomu Nakashima; Tadao Yoshida; Jing Zou; Shinji Naganawa
Journal:  BMJ Open       Date:  2013-02-14       Impact factor: 2.692

2.  Atmospheric Pressure and Onset of Episodes of Menière's Disease - A Repeated Measures Study.

Authors:  Robert Gürkov; Ralf Strobl; Nina Heinlin; Eike Krause; Bernhard Olzowy; Christina Koppe; Eva Grill
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

Review 3.  What is Menière's disease? A contemporary re-evaluation of endolymphatic hydrops.

Authors:  R Gürkov; I Pyykö; J Zou; E Kentala
Journal:  J Neurol       Date:  2016-04-15       Impact factor: 4.849

4.  Disease Profiling for Computerized Peer Support of Ménière's Disease.

Authors:  Jyrki Rasku; Ilmari Pyykkö; Hilla Levo; Erna Kentala; Vinaya Manchaiah
Journal:  JMIR Rehabil Assist Technol       Date:  2015-09-03

5.  Characterization of Balance Problems and Rehabilitation Needs of Patients with Ménière's Disease.

Authors:  Ilmari Pyykkö; Nora Pyykkö; Jing Zou; Vinaya Manchaiah
Journal:  Audiol Res       Date:  2022-01-05

6.  Quality of Life Following Cochlear Implantation in Patients With Menière's Disease.

Authors:  Isabel Sanchez-Cuadrado; Miryam Calvino; Jose Manuel Morales-Puebla; Javier Gavilán; Teresa Mato; Julio Peñarrocha; Maria Pilar Prim; Luis Lassaletta
Journal:  Front Neurol       Date:  2021-06-17       Impact factor: 4.003

7.  Impact evaluation and association with EuroQol 5D health-related utility values in Ménière's disease.

Authors:  Ilmari Pyykkő; Vinaya Manchaiah; Hilla Levo; Erna Kentala
Journal:  Springerplus       Date:  2015-11-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.